Merck, Lilly and Pfizer to Construct Asian Cancer Database

Three of big pharma’s biggest companies, Merck, Lilly and Pfizer, have banded together to create an Asian not-for-profit company that will construct a pharmacogenomic cancer database in Singapore. The database will compile its information using 2,000 tissue samples from patients with lung and gastric cancer. The information will be made available to researchers with the goal of developing new treatments for gastric and lung cancers, which are prevalent in Asia. More details... Stock Symbols: (NYSE: MRK) (NYSE: LLY) (NYSE: PFE)